NSG 124 FINAL EXAM – PHARMACOLOGY (2026/2027) QUESTIONS
AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES
2026 Q&A | INSTANT DOWNLOAD PDF
Core Domains
• Pharmacokinetics and Pharmacodynamics
• Cardiovascular Pharmacology
• Respiratory Pharmacology
• Endocrine Pharmacology
• Central Nervous System Pharmacology
• Antimicrobial Therapy
• Gastrointestinal Pharmacology
• Medication Safety and Administration
• Lifespan Considerations in Pharmacotherapy
• Drug Interactions and Adverse Effects
Introduction
This comprehensive examination is designed to evaluate the essential
pharmacological knowledge required for safe and effective medication
administration in nursing practice. The assessment covers
pharmacokinetic and pharmacodynamic principles, therapeutic
applications of major drug classes, and evidence-based nursing
considerations across the lifespan. The multiple-choice format
integrates NCLEX-style clinical scenarios that require synthesis of
patient-specific factors, drug mechanisms, and treatment guidelines to
optimize therapeutic outcomes. Candidates are expected to
demonstrate mastery of pharmacotherapeutics, including appropriate
drug selection, monitoring parameters, and identification of adverse
effects and interactions. This examination serves as a rigorous
evaluation of readiness for professional nursing practice.
,SECTION ONE: QUESTIONS 1–100
1. What is the definition of pharmacokinetics?
A. The study of drug effects on the body (what the drug does to the
body)
B. The study of drug movement through the body (absorption,
distribution, metabolism, excretion)
C. The study of drug interactions
D. The study of drug toxicity
B. The study of drug movement through the body (absorption,
distribution, metabolism, excretion)
RATIONALE: Pharmacokinetics describes what the body does to the
drug, encompassing Absorption, Distribution, Metabolism, and
Excretion (ADME). Pharmacodynamics describes what the drug does to
the body .
2. Which route of administration has the fastest onset of action?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
D. Intravenous
RATIONALE: IV administration delivers the drug directly into the
bloodstream, achieving 100% bioavailability and the fastest onset. Oral
drugs must be absorbed through the GI tract, which delays onset .
,3. Bioavailability refers to:
A. The percentage of an administered drug that reaches systemic
circulation
B. The time it takes for a drug to reach peak concentration
C. The amount of drug excreted in urine
D. The binding of drug to plasma proteins
A. The percentage of an administered drug that reaches systemic
circulation
RATIONALE: Bioavailability (F) is the fraction of an administered
dose that reaches systemic circulation unchanged. Oral drugs have
lower bioavailability due to first-pass metabolism .
4. The "first-pass effect" refers to:
A. Metabolism of a drug in the liver before it reaches systemic
circulation
B. The time required for a drug to reach peak concentration
C. The time required for a drug to be absorbed
D. The time required for a drug to be distributed to tissues
A. Metabolism of a drug in the liver before it reaches systemic
circulation
RATIONALE: The first-pass effect occurs when orally administered
drugs are metabolized by the liver before reaching systemic circulation,
reducing bioavailability .
5. What is the definition of a drug's half-life (t½)?
, A. The time required for a drug to reach peak concentration
B. The time required for a drug to be absorbed
C. The time required for the plasma concentration to decrease by 50%
D. The time required for a drug to be distributed to tissues
C. The time required for the plasma concentration to decrease by
50%
RATIONALE: Half-life is the time required for the plasma
concentration of a drug to decrease by 50% during elimination. It
determines dosing frequency .
6. A drug with a short half-life (e.g., 2 hours) is typically administered:
A. More frequently (every 4-6 hours)
B. Less frequently (once daily)
C. Only once
D. Never
A. More frequently (every 4-6 hours)
RATIONALE: Drugs with short half-lives require more frequent
administration to maintain therapeutic levels .
7. How many half-lives are required to reach steady state?
A. 4-5 half-lives
B. 1 half-life
C. 2 half-lives
D. 10 half-lives
AND CORRECT ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES
2026 Q&A | INSTANT DOWNLOAD PDF
Core Domains
• Pharmacokinetics and Pharmacodynamics
• Cardiovascular Pharmacology
• Respiratory Pharmacology
• Endocrine Pharmacology
• Central Nervous System Pharmacology
• Antimicrobial Therapy
• Gastrointestinal Pharmacology
• Medication Safety and Administration
• Lifespan Considerations in Pharmacotherapy
• Drug Interactions and Adverse Effects
Introduction
This comprehensive examination is designed to evaluate the essential
pharmacological knowledge required for safe and effective medication
administration in nursing practice. The assessment covers
pharmacokinetic and pharmacodynamic principles, therapeutic
applications of major drug classes, and evidence-based nursing
considerations across the lifespan. The multiple-choice format
integrates NCLEX-style clinical scenarios that require synthesis of
patient-specific factors, drug mechanisms, and treatment guidelines to
optimize therapeutic outcomes. Candidates are expected to
demonstrate mastery of pharmacotherapeutics, including appropriate
drug selection, monitoring parameters, and identification of adverse
effects and interactions. This examination serves as a rigorous
evaluation of readiness for professional nursing practice.
,SECTION ONE: QUESTIONS 1–100
1. What is the definition of pharmacokinetics?
A. The study of drug effects on the body (what the drug does to the
body)
B. The study of drug movement through the body (absorption,
distribution, metabolism, excretion)
C. The study of drug interactions
D. The study of drug toxicity
B. The study of drug movement through the body (absorption,
distribution, metabolism, excretion)
RATIONALE: Pharmacokinetics describes what the body does to the
drug, encompassing Absorption, Distribution, Metabolism, and
Excretion (ADME). Pharmacodynamics describes what the drug does to
the body .
2. Which route of administration has the fastest onset of action?
A. Oral
B. Subcutaneous
C. Intramuscular
D. Intravenous
D. Intravenous
RATIONALE: IV administration delivers the drug directly into the
bloodstream, achieving 100% bioavailability and the fastest onset. Oral
drugs must be absorbed through the GI tract, which delays onset .
,3. Bioavailability refers to:
A. The percentage of an administered drug that reaches systemic
circulation
B. The time it takes for a drug to reach peak concentration
C. The amount of drug excreted in urine
D. The binding of drug to plasma proteins
A. The percentage of an administered drug that reaches systemic
circulation
RATIONALE: Bioavailability (F) is the fraction of an administered
dose that reaches systemic circulation unchanged. Oral drugs have
lower bioavailability due to first-pass metabolism .
4. The "first-pass effect" refers to:
A. Metabolism of a drug in the liver before it reaches systemic
circulation
B. The time required for a drug to reach peak concentration
C. The time required for a drug to be absorbed
D. The time required for a drug to be distributed to tissues
A. Metabolism of a drug in the liver before it reaches systemic
circulation
RATIONALE: The first-pass effect occurs when orally administered
drugs are metabolized by the liver before reaching systemic circulation,
reducing bioavailability .
5. What is the definition of a drug's half-life (t½)?
, A. The time required for a drug to reach peak concentration
B. The time required for a drug to be absorbed
C. The time required for the plasma concentration to decrease by 50%
D. The time required for a drug to be distributed to tissues
C. The time required for the plasma concentration to decrease by
50%
RATIONALE: Half-life is the time required for the plasma
concentration of a drug to decrease by 50% during elimination. It
determines dosing frequency .
6. A drug with a short half-life (e.g., 2 hours) is typically administered:
A. More frequently (every 4-6 hours)
B. Less frequently (once daily)
C. Only once
D. Never
A. More frequently (every 4-6 hours)
RATIONALE: Drugs with short half-lives require more frequent
administration to maintain therapeutic levels .
7. How many half-lives are required to reach steady state?
A. 4-5 half-lives
B. 1 half-life
C. 2 half-lives
D. 10 half-lives
